| Filed On | Filing |
|---|---|
| 26 Oct 2026 | SCHEDULE 13D |
| 21 Oct 2026 |
Form 3: Gravitas Collective Corp., Director
Holds 25,000,000 shares of Common Stock |
| 21 Oct 2026 | SCHEDULE 13G/A |
| 14 Oct 2026 | S-8 |
| 09 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more
This Membership Interest Purchase Agreement (this “Agreement”), dated as of October 6, 2026, by and among Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), Gravitas Life Sciences, LLC, a Delaware limited liability compa... |
| 02 Oct 2026 |
Form 4: Fisher Danina, Director
Bought 200,000 shares ($10K) · Acquired 200,000 Warrants (Open Market Purchase) |
| 02 Oct 2026 |
8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
HEPION PHARMACEUTICALS, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows: |
| 28 Sep 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read the statements made by Hepion Pharmaceuticals, Inc. under Item 4.01 of its Form 8-K dated September 24, 2026, and we agree with the statements concerning our Firm in such Form 8-K. We have no basis to agree or disagree with ... |
| 16 Sep 2026 |
Form 3: Ki Holdings, Ltd., 10% owner
Holds 10,000,000 shares of Common Stock |
| 16 Sep 2026 | SCHEDULE 13D/A |
| 15 Sep 2026 | SCHEDULE 13G |
| 14 Sep 2026 |
Form 4: LoPriore Vincent S, Director
Acquired 12,500,000 Warrants (Open Market Purchase) |
| 10 Sep 2026 | DEF 14C |
| 10 Sep 2026 |
Form 4: Purcell Michael J., Director
Granted 299,000 Stock Options |
| 08 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (the “Agreement”) is made as of September 3, 2026, by and between Hepion Pharmaceuticals, Inc., a Delaware corporation (and together with all of its current and future, direct and/or indirect, who... |
| 31 Aug 2026 | PRE 14C |
| 27 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 21 Aug 2026 |
Form 4: Stetz Gary S., Director
Granted 1,345,500 Stock Options |
| 21 Aug 2026 |
Form 4: LoPriore Vincent S, Director
Granted 1,345,500 Stock Options |
| 21 Aug 2026 |
Form 4: LoPriore Chase, Director
Granted 1,345,500 Stock Options |
Loading...